Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Depression 6Neoplasms 5Anxiety Disorders 5Melanoma 2Depressive Disorder, Major 2Pain 1Osteosarcoma 1Opioid-Related Disorders 1Neoplasm Metastasis 1Lymphoma 1Hospice 1Hematopoietic and Lymphatic System Neoplasm 1Endocrine Gland Neoplasms 1Depressive Disorder 1Caregiver Distress 1Carcinoma, Non-Small-Cell Lung 1Agnosia 1

Interventions

Specimen Handling 4Interviews as Topic 2merphos 1axatilimab 1X-Rays 1Tacrolimus 1Stem Cell Transplantation 1Spinal Puncture 1Resistance Training 1Psychotherapy 1Psilocybin 1Phantoms, Imaging 1Organizational Objectives 1Mycophenolic Acid 1Methotrexate 1Magnetic Resonance Spectroscopy 1Hydrocortisone 1Cytarabine 1Cyclophosphamide 1BNT162 Vaccine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hematopoietic and Lymphatic System Neoplasm × Psilocybin × Clear all
NCT06827054 2026-03-24

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Roswell Park Cancer Institute

Phase 2 Not yet recruiting
20 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡